|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY.
Correspondence to: Sunil Dhuper, MD, FCCP, Department of Medicine, North Central Bronx Hospital, 3424 Kossuth Ave, Bronx, NY 10467; e-mail: dhupernbhn{at}aol.com
| Abstract |
|---|
|
|
|---|
Design: Retrospective review of patient histories and medical records.
Setting: Medical ICU and inpatient medical ward of an inner-city university hospital.
Patients: Asthma patients requiring mechanical ventilation.
Methods: Seventy episodes of NFA requiring endotracheal intubation (intubation group [IG]) and 523 hospital admissions with acute asthma (nonintubation group [NIG]) were analyzed over a 4-year period from January 1997 to September 2000. Prior intubation(s), duration of symptoms, steroid dependence, and knowledge and use of inhaled corticosteroids and SC were noted. Indications for mechanical ventilation, ventilatory parameters using permissive hypercapnia, sedation/paralysis, duration, extubation criteria, complications, and outcome were analyzed.
Results: Twenty-nine of 70 patients (41.4%) in the IG had at least one prior episode of NFA requiring mechanical ventilation, compared to 123 of 523 patients (23.5%) in the NIG (p < 0.005). Ten of 70 patients (14.3%) in the IG were steroid dependent, compared to 40 of 523 patients (7.6%) in the NIG (p < 0.05). Forty of 70 patients (57%) in the IG compared to 308 of 523 patients (59%) in the NIG reported noncompliance with prescribed inhaled corticosteroids (not significant). All received aerosolized ß-agonist therapy, but only 11 of 70 patients (15.7%) initiated SC therapy in the IG compared to 145 of 523 patients (27.7%) in the NIG (p < 0.05). Even with symptoms > 48 h, 34 of 43 patients (79%) in the IG did not receive SC. Three patients died and four patients acquired myopathy in the IG.
Conclusion: History of intubation and steroid dependence were identified as risk factors for future intubation. Our patients with asthma in both the IG and NIG were noncompliant with inhaled corticosteroids. Despite a long duration of symptoms and knowledge of SC, the majority neither implemented self-management with SC nor contacted an HCP. Early initiation of SC (symptoms < 48 h) might have averted intubation in the high-risk group. Most of our patients were extubated successfully in < 48 h. Incidence of barotrauma was very low, probably due to utilization of permissive hypercapnia.
Key Words: corticosteroids mechanical ventilation near-fatal asthma
| Introduction |
|---|
|
|
|---|
Mechanical ventilation for asthma is a relatively rare occurrence; however, asthma patients who require mechanical ventilation have a high morbidity and mortality. Patients with a severe asthma attack who have survived an episode of endotracheal intubation and mechanical ventilation for acute respiratory failure are designated to have experienced near-fatal asthma (NFA). Several studies4 5 6 revealed that such patients are at increased risk of a similar severe attack and, hence, death in the future. As early recognition of a severe attack and treatment with systemic corticosteroids (SC) is essential to improve outcome for NFA, we analyzed our patients knowledge and practices prior to presentation.
The aims of this study were to evaluate patients presenting with NFA for the following: their ability to recognize the increasing severity of the asthma exacerbation; their ability to seek timely help from a health-care provider (HCP); their knowledge of corticosteroid use, inhaled and systemic; their implementation of such therapy; and their hospital course, especially mechanical ventilation and outcomes.
| Materials and Methods |
|---|
|
|
|---|
All patients were initially evaluated in the ED and admitted to either the medical ICU or the medical floor. Indications for hospitalization were based on the guidelines defined by National Asthma Education and Prevention Program.8 Although indications for mechanical ventilation in acute asthma exist, many of these guidelines are arbitrary. Indications for intubation and mechanical ventilation in our study fell into two categories: immediate intubation and delayed intubation. A decision was made to administer mechanical ventilation immediately in the event of cardiopulmonary arrest, loss of consciousness, and/or altered mental status. Patients in the delayed category were treated with humidified oxygen, nebulized albuterol, 2.5 mg every 15 min three times and then every 1 h; epinephrine, 1:1000 concentration, 0.3 mL subcutaneously every 15 min three times in some cases; and high dose IV steroids in all cases. Mechanical ventilation was instituted if patients demonstrated deteriorating gas exchange and respiratory failure documented by arterial blood gas or if clinical parameters suggested impending respiratory failure (indicated by tachycardia, worsening respiratory distress with use of accessory muscles, exhaustion or fatigue in the judgment of physician or patient, and deteriorating peak expiratory flow rates).
Patients received controlled mechanical ventilation utilizing the principles of permissive hypercapnia. The ventilator settings were adjusted to maintain peak airway pressure < 50 cm H2O, irrespective of the PCO2 level. Sedation was maintained with benzodiazepines or propofol, either IV push or continuous infusion. Neuromuscular blocking agents were used sparingly and only if the above measures failed to achieve the target peak pressure. The inspiratory to expiratory ratio was usually maintained between 1:3 and 1:4. The fraction of inspired oxygen was adjusted to maintain a PaO2 > 60 mm Hg. Patients were maintained on mechanical ventilation until peak airway pressures decreased to
35 cm H2O for at least 2 h off sedation and then extubated.
Patients with asthma exacerbation who did not require intubation (nonintubation group [IG]) received similar treatment with humidified oxygen; nebulized albuterol, 2.5 mg every 15 min three times, and then every 4 to 6 h; and IV corticosteroids based on our standard asthma treatment regimen.
Data Collection
We conducted interviews of all patients based on a questionnaire developed by the pulmonary service. We elicited detailed history of the patients asthma, current episode of asthma, previous hospitalizations, circumstances leading to the previous hospitalizations, and episodes of NFA. For current episode, the patient was asked to identify the precipitating event, if known, to quantify the duration of symptoms prior to presentation to the emergency department, to list of medications they are prescribed and their actual use of any, and to describe their use of corticosteroids, both aerosol and oral forms in the past and in the 1 month preceding the current admission. They were asked to describe their pattern of health-care utilization; to note whether they had previously received information about asthma and its treatment, specifically the prior instruction on the use of oral corticosteroids during acute asthma attack; and to note whether they were prescribed a spacer and a peak flowmeter. For those who required mechanical ventilation, we scrutinized the records of the ED and the emergency medical service (EMS) to find the indications for mechanical ventilation, ventilatory parameters, and use of sedation and paralytics. The chart was further reviewed to obtain the trend in the ventilatory parameters, use of sedatives and paralytics, extubation criteria, complications, and outcome.
| Results |
|---|
|
|
|---|
Multiple episodes of NFA were not uncommon. Of the 70 episodes of endotracheal intubation, 29 episodes (41.4%) were among patients with at least one prior episode of NFA. Thirteen of these episodes (18.5%) were in patients with a history of three or more previous intubations. Compared to the IG, 123 of 523 patients (23.5%) in the NIG had at least one prior episode of NFA (p < 0.005). Indications for endotracheal intubation included 17 episodes (24%) for altered mental status and 28 episodes (40%) of deteriorating gas exchange on arterial blood gas analysis. Intubation was required for impending respiratory failure in the judgment of the ED attending physician/EMS in the remaining 25 episodes (36%). Ten of 70 patients (14.3%) were steroid dependent in the IG, compared to 40 of 523 patients (7.6%) in the NIG (p < 0.05).
The knowledge and practices of our study group as to treatment strategy prior to presentation, especially corticosteroid use, are outlined in Table 1 . Only 7 of 70 patients (10%) with NFA contacted an HCP, compared to 105 of 523 patients (20%) in the NIG (not significant [NS]). The majority self-managed their asthma exacerbation in both groups. All patients reported using ß-agonist therapy either via metered-dose inhaler and/or nebulizer. Only 30 of 70 patients (43%) in the IG and 215 of 523 patients (41%) in the NIG reported to have received at least 50% of the prescribed inhaled steroid dose in the preceding month. Among the total study population, only 11 of 70 patients (15.7%) in the IG initiated oral corticosteroids prior to endotracheal intubation, compared to 145 of 523 patients (27.7%) in the NIG (p < 0.05).
|
|
|
| Discussion |
|---|
|
|
|---|
In this study, we focused on the characteristics and practices of our adult patient population with moderate-to-severe asthma presenting with NFA in an effort to better understand the factors affecting early recognition, treatment implementation, and possible prevention. Forty-one percent of patients in our study group had a history of at least one prior intubation, compared to 23% in the NIG, supporting the finding of increased risk of NFA among patients with a previous history of a similar episode.21
22
23
24
As multiple intubations were not uncommon, emphasis on better overall asthma management of these high-risk patients with chronic anti-inflammatory therapy is essential. Steroid dependence was twice as high in the IG compared to the NIG. In one study,28
a significant reduction in the risk of NFA was shown among patients dispensed
12 canisters per year of inhaled corticosteroids. In our study group, we found that 60% of the patients were nonadherent to steroid inhaler use, similar to the adherence rate reported in other studies.21
26
These patients tended to have poor routine care without follow-up in any medical setting, and many used multiple EDs as their primary source of asthma care. As we were not able to successfully influence chronic management, we wanted to further examine acute self-management by these patients prior to presentation.
One of the most important aspects in management of patients at risk for NFA is initiation of SC therapy at the onset of asthma symptoms or timely contact with an HCP. It is disturbing that the majority of our patients had neither instituted SC therapy nor contacted an HCP. Their knowledge of self-management with SC was not implemented. Their fear of side effects of SC, underestimation of attack severity, and prior experience with attacks that had ameliorated without SC made them take a "wait and see" attitude. The fear of complications from SC is pervasive among our asthma patients despite our efforts to educate them of the relative safety of short-burst therapy with oral corticosteroids. Weight gain is of concern especially among young female patients.
Even though the above-mentioned aspects of asthma education are very important, the most critical part of asthma education is to train our patients to recognize the warning signs of life-threatening asthma. All of our patients claimed that they would have either started steroids or contacted an HCP if they had recognized the severity of their asthma. Subjective assessment of asthma severity based on the patients perception of symptoms can be quite deceptive. Serial measurement of peak expiratory flow rate is an objective assessment widely used for home monitoring of asthma8 ; however, most of the patients in this study did not own a peak flowmeter, and even the few who owned one did not use it. Instead, they relied on their subjective sensation of asthma. It may be more suitable for our patients to rely on the increasing need for a ß-agonist as a trigger to initiate SC therapy. Patients in our clinic are usually instructed to initiate SC therapy when they increase ß-agonist use to seven or more times in a given day. Those who typically have slow progression of asthma over several days are told to initiate SC therapy when they experience nocturnal worsening of asthma, having to wake up once or more, for 2 consecutive nights.
Clearly, we documented an improvement in the outcome of patients receiving mechanical ventilation for acute asthma. In the past, studies11
12
13
14
15
16
17
18
19
20
29
have shown a significant mortality associated with mechanical ventilation for asthma; however, this is not our experience. Most of our patients were extubated successfully in < 48 h, and the overall complication rate especially from barotrauma was very low, probably because of the use of permissive hypercapnia and maintenance of low peak airway pressure. We found our extubation criteria to be safe and reliable. Patients were extubated when the peak airway pressure decreased to
35 cm H2O for 2 h and they were fully awake from sedation.
In conclusion, we have shown that the patients in both groups had poor adherence to inhaled corticosteroids. NFA patients were more likely to have experienced prior endotracheal intubations and to be steroid dependent. Patients with NFA are particularly reluctant to use SC despite their favorable experience with SC in the past and they had adequate time to implement SC therapy. Efforts should be made to stress early asthma intervention and to focus on early recognition of warning signs of objective evidence, ie, measurement of serial peak expiratory flow rates and the increasing need for ß-agonists. Furthermore, our patients with moderate-to-severe asthma need to change their perception of short-burst corticosteroid therapy and accept it as a safe modality of self-management. This needs to be stressed in the ED, during hospital admissions, and in primary care clinics. Such an approach may prevent future episodes of NFA.
| Footnotes |
|---|
This work was performed at Jacobi Medical Center, Bronx, NY.
Received for publication December 28, 2001. Accepted for publication April 4, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. M. Levy Pathophysiology of Oxygen Delivery in Respiratory Failure Chest, November 1, 2005; 128(5_suppl_2): 547S - 553S. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |